|Research to better understand and treat the number one birth defect in the United States, congenital heart defects (CHDs), is getting a boost thanks to a joint $1.3 million commitment from the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, and The Children’s Heart Foundation, the nation’s leading organization dedicated to funding congenital heart defect research.
This is the seventh round of their co-funded Congenital Heart Defect Research Awards program, and is distributed among eight research projects nationwide. The American Heart Association and The Children’s Heart Foundation have pledged a total of $14.3 million to fund CHD research over the next several years.
The grants have been awarded to:
“By funding research into what causes congenital heart defects and how to better treat people living with them, we are laying the groundwork for more children to survive into healthy adulthoods,” said Dianne Atkins, MD, American Heart Association volunteer medical expert and Professor of Pediatrics, Emerita, Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa. “Research is in the American Heart Association’s DNA. Supporting innovative research to help save and improve the lives of children is of utmost importance to us.”
Nearly 40,000 infants are born with congenital heart defects each year in the United States. About 25 percent of babies born with a CHD require invasive treatment in their first year of life. Research that helps understand, identify, and treat CHDs is helping these children live longer, healthier lives. While medical advancements have improved over the years, many of these children and their families still face a lifetime of challenges. Today, it is estimated that more than 800,000 American adults are living with a CHD.
“Through this collaboration and our ongoing commitment to advancing the diagnosis, treatment, and prevention of congenital heart defects, we strive to make a lasting impact on the lives of CHD patients and their families,” said Barbara Newhouse, CEO of The Children’s Heart Foundation. “This new research will help bring innovative solutions to improve survival rates and care for all individuals living with CHDs.”
Scientists who are conducting research on congenital heart defects to advance knowledge for prevention and treatment are encouraged to submit applications for the next round of funding. For more about the American Heart Association and The Children’s Heart Foundation Congenital Heart Defects Research Awards, including deadlines for submitting proposals, please visit www.professional.heart.org/CHDResearchAwards.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
About The Children’s Heart Foundation
The Children’s Heart Foundation is the country’s leading organization solely committed to funding congenital heart defect (CHD) research. The Children’s Heart Foundation’s mission is to fund the most promising research to advance the diagnosis, treatment, and prevention of congenital heart defects. To date, The Children’s Heart Foundation has funded more than $13 million dollars of CHD research and scientific collaborations. For more information or to join our cause, visit www.childrensheartfoundation.org. Follow us on Facebook, Instagram, and Twitter.
For Media Inquiries:
American Heart Association:
Linzy Cotaya, [email protected]; (504) 872-3446
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
The Children’s Heart Foundation:
Lauren DeVoe, [email protected]; (224) 458-4505
For Public Inquiries: (847) 634-6474